LidoTape - V2 Pharma LLC

Manufacturer
V2 Pharma LLC
Effective date
2026-04-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:53:37

Label at a glance#

ProductLidoTape
Active ingredientLIDOCAINE
Label structure9 sections

Dosage and administration

adults and children over 12 years: • apply strip for up to 12 hours of wear time • apply 1 strip at a time to the affected area, not more than 2 to 3 times daily • store in a cool dry place children 12 years or younger: ask a doctor

Label contents#

Full prescribing information#

LidoTape - Lidocaine 4% Kinesiology Tape

DESCRIPTION SECTION

1 LidoTape roll contains 20 medicated pre-cut strips of lidocaine 4% kinesiology tape

1 roll of LidoTape per box

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Topical analgesic

Use

INDICATIONS & USAGE SECTION

For the temporary relief of pain

Warnings

WARNINGS SECTION

for external use only
When using this product
• use only as directed. Read and follow all directions and warnings on this package
• do not bandage tightly
• avoid contact with eyes and mucous membranes
• do not use at the same time as other topical analgesics
• do not remove when wet or directly after shower, allow to dry and then slowly remove

Stop use and ask a doctor if
• condition worsens
• symptoms persist for more than 7 days or clear up and occur again within a few days
• you experience signs of skin injury, such as pain, swelling or blistering where the tape was applied
• If pregnant or breast-feeding, ask a health professional before use

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

• If swallowed, get medical help or contact a Poison Control Center right away

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children over 12 years:
• apply strip for up to 12 hours of wear time
• apply 1 strip at a time to the affected area, not more than 2 to 3 times daily
• store in a cool dry place
children 12 years or younger: ask a doctor

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Acrylic adhesive, Flaxseed oil, and Polysorbate 80

SPL UNCLASSIFIED SECTION

Manufactured in the USA for V2 Pharma, LLC

Questions/Comments: +1 (800) 519-8334

V2 Pharma, LLC

8210 SW Nimbus Avenue

Beaverton, OR 97008

Packaging for LidoTape is shown below

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LidoTape PackagingLidoTape Packaging

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1737778lidocaine 4 % Medicated PatchPSN1
1737778lidocaine 0.04 MG/MG Medicated PatchSCD1
1737778lidocaine 4 % Medicated PatchSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72835-040-20LidoTape20 in 1 POUCHTAPE201
72835-040-20LidoTape1 in 1 BOXTAPE11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72835-04072835-040-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LidoTapeLIDOCAINE 4%V2 Pharma LLCed18b4f7-6a2c-4dce-9b53-e485569093c52026-04-09WarningsExact identifier
ndc (package): 72835-040-20
ndc (product): 72835-040
ndc11 (package): 72835004020
spl id: 2f22d980-c78d-4b07-a4b9-94f831c52b8c
spl set id: ed18b4f7-6a2c-4dce-9b53-e485569093c5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.